LBB Specialties (LBBS), a leader in specialty chemicals and ingredient distribution in North America, announces a new partnership with SE Tylose USA for cellulose excipients in the Pharma Excipients ...
A heart surgeon who performed a revolutionary aortic valve replacement therapy on patients with heart valve failure undergoes ...
“The new dedicated life sciences organization represents a significant advancement in how we approach health security. It will enhance our ability to support a swift response to health emergencies, ...
Work has begun on a 23-storey life sciences tower in Canary Wharf. Developers Canary Wharf Group and Dutch investor Kadans ...
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and SK ...
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today ...
Zacks.com on MSN2h
WVE Stock Soars on Upbeat Efficacy Data From Muscle Disease StudyShares of Wave Life Sciences WVE surged 53.4% on Tuesday after the company announced positive interim data from a mid-stage ...
Shares in Wave rose 53% after the trial data was announced, taking its market cap above the $1 billion threshold. The company ...
The program is helping create a pipeline for future health care workers, hopefully helping fill a sorely needed gap in Rhode ...
Sri’s ability to lead through change is exemplified by his role in expanding a COVID-19 testing program, where he ...
Research organisations Biowaived, Matheus Engineering and Particology Ltd have all been created by former Pfizer staff. Their ...
Edwards Lifesciences (NYSE: EW), a medical technology company specializing in artificial heart valves, currently trades at $67 per share, about 50% lower than the peak level of $131 seen in December ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback